Holekamp N M
Barnes Retina Institute, St. Louis, MO 63110, USA.
Ocul Immunol Inflamm. 1998 Jun;6(2):121-3. doi: 10.1076/ocii.6.2.121.4053.
Pseudophakic cystoid macular edema is now an infrequent complication of cataract surgery. However, since cataract surgery continues to be one of the most commonly performed surgical procedures, the prevalence of pseudophakic cystoid macular edema is high. In addition, although pseudophakic cystoid macular edema has been a well-defined entity since the 1950s and 1960s, little progress has been made in understanding its pathogenesis or in deriving an effective treatment of the condition. While acute pseudophakic cystoid macular edema may resolve spontaneously, chronic visually significant pseudophakic cystoid macular edema remains difficult to treat. Nonsteroidal anti-inflammatory agents and corticosteroids in various forms can be used, but each type of treatment lacks satisfactory success. Eyes with abnormal vitreous or refractory to medical therapy can be improved with vitrectomy surgery. It must be concluded, however, that there is a real need for significant advances in both the understanding and treatment of pseudophakic cystoid macular edema.
人工晶状体性黄斑囊样水肿如今是白内障手术中一种不常见的并发症。然而，由于白内障手术仍是最常开展的外科手术之一，人工晶状体性黄斑囊样水肿的患病率很高。此外，尽管自20世纪五六十年代以来人工晶状体性黄斑囊样水肿就是一个明确的病症，但在了解其发病机制或找到有效的治疗方法方面进展甚微。虽然急性人工晶状体性黄斑囊样水肿可能会自行消退，但慢性且具有明显视力影响的人工晶状体性黄斑囊样水肿仍然难以治疗。可以使用各种形式的非甾体抗炎药和皮质类固醇，但每种治疗方法的成功率都不尽人意。玻璃体异常或对药物治疗无效的眼睛可通过玻璃体切除术得到改善。然而，必须得出的结论是，在人工晶状体性黄斑囊样水肿的理解和治疗方面确实需要取得重大进展。
